Immediate Impact
3 standout
Citing Papers
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
2023 Standout
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
2022 Standout
Works of Tim Mandelkow being referenced
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tim Mandelkow | 6 | 11 | 5 | 5 | 6 | 14 | |
| Timothy Langford | 6 | 7 | 3 | 8 | 7 | 19 | |
| Valentina Serra | 4 | 8 | 7 | 4 | 6 | 23 | |
| Manman Cui | 4 | 11 | 2 | 3 | 5 | 19 | |
| Yuping Li | 6 | 12 | 3 | 3 | 8 | 21 | |
| Haibo Xu | 3 | 8 | 2 | 5 | 6 | 14 | |
| Nils Rouven Hansmeier | 8 | 8 | 3 | 3 | 5 | 24 | |
| Nancy Roche | 3 | 8 | 2 | 5 | 5 | 17 | |
| Julia E. Rudolph | 6 | 10 | 6 | 7 | 7 | 22 | |
| Rômulo Leopoldo de Paula Costa | 9 | 6 | 6 | 3 | 4 | 15 | |
| Austin Burcham | 12 | 7 | 6 | 2 | 6 | 23 |
All Works
Login with ORCID to disown or claim papers
Loading papers...